No products in the cart.
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
AstraZeneca is in discussions to acquire Bristol Myers Squibb in a deal valued at approximately…
AstraZeneca is in discussions to acquire Bristol Myers Squibb in a deal valued at approximately…
Science Corporation's PRIMA chip, recently approved by the EU, aims to restore vision lost…
Anthropic aims to leverage AI in drug development, focusing on treatments for neglected…
Novo Nordisk, the maker of the obesity drug Ozempic, is launching a series of incubators across…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.